Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 48968 questions Show Answers
To ask the Scottish Government what it is doing to reduce the number of people with myeloma diagnosed through an emergency route.
To ask the Scottish Government what the reasons are for the reported delays to the implementation of the Children (Scotland) Act 2020, and whether it will update the Parliament on its progress before the summer recess.
To ask the Scottish Government when it expects to lay regulations related to child contact centres under the Children (Scotland) Act 2020.
To ask the Scottish Government how many people have been diagnosed with myeloma through the Rapid Cancer Diagnostic Service.
To ask the Scottish Government what role the Scottish Public Pensions Agency (SPPA) has in managing the Scottish Teachers' Pension Scheme (STPS), and how teachers can raise any concerns or enquiries regarding their pension plan.
To ask the Scottish Government whether it will provide an update on the projected costs of the Scottish Teachers' Pension Scheme (STPS) over the next five years, and whether it will outline any measures being considered to ensure its long-term sustainability.
To ask the Scottish Government whether there are any provisions within the Scottish Teachers' Pension Scheme (STPS) that allow teachers to adjust their contribution rates to potentially increase their future pension benefits.
To ask the Scottish Government whether it has any plans to mark Coeliac Awareness Month in May 2024, and what strategies it has in place to raise awareness of the condition.
To ask the Scottish Government what measures it is taking to promote coordination between schools and mental health services.
To ask the Scottish Government what barriers there have been to the implementation of placental growth factor (PlGF)-based tests, and what action it is taking to resolve any such barriers.